fanta.bio Sample: CNhs11317
11699 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 648 / 6329 (10.2%) | 235 / 63290 (0.4%) | −324.0 | −324.0 | 27.57 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 942 / 6329 (14.9%) | 406 / 63290 (0.6%) | −324.0 | −324.0 | 23.20 |
| HIF1A SRX11007095 | HK-2 Kidney | 1020 / 6329 (16.1%) | 517 / 63290 (0.8%) | −324.0 | −324.0 | 19.73 |
| SCML2 SRX644728 | 293 Kidney | 750 / 6329 (11.9%) | 388 / 63290 (0.6%) | −324.0 | −324.0 | 19.33 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 738 / 6329 (11.7%) | 421 / 63290 (0.7%) | −324.0 | −324.0 | 17.53 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1007 / 6329 (15.9%) | 597 / 63290 (0.9%) | −324.0 | −324.0 | 16.87 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1022 / 6329 (16.1%) | 627 / 63290 (1.0%) | −324.0 | −324.0 | 16.30 |
| BRD4 SRX9419935 | BT-474 Breast | 1500 / 6329 (23.7%) | 1390 / 63290 (2.2%) | −324.0 | −324.0 | 10.79 |
| BRD4 SRX9419937 | BT-474 Breast | 1464 / 6329 (23.1%) | 1406 / 63290 (2.2%) | −324.0 | −324.0 | 10.41 |
| MED1 SRX9419944 | BT-474 Breast | 1418 / 6329 (22.4%) | 1373 / 63290 (2.2%) | −324.0 | −324.0 | 10.33 |
| MED1 SRX9419945 | BT-474 Breast | 1452 / 6329 (22.9%) | 1418 / 63290 (2.2%) | −324.0 | −324.0 | 10.24 |
| BRD4 SRX9419936 | BT-474 Breast | 1488 / 6329 (23.5%) | 1457 / 63290 (2.3%) | −324.0 | −324.0 | 10.21 |
| MED1 SRX9419946 | BT-474 Breast | 1471 / 6329 (23.2%) | 1457 / 63290 (2.3%) | −324.0 | −324.0 | 10.10 |
| MED1 SRX9419947 | BT-474 Breast | 1411 / 6329 (22.3%) | 1419 / 63290 (2.2%) | −324.0 | −324.0 | 9.94 |
| BRD4 SRX9419938 | BT-474 Breast | 1433 / 6329 (22.6%) | 1452 / 63290 (2.3%) | −324.0 | −324.0 | 9.87 |
| EZH2 SRX2146136 | LNCAP Prostate | 3090 / 6329 (48.8%) | 3700 / 63290 (5.8%) | −324.0 | −324.0 | 8.35 |
| BRD4 SRX736201 | 90-8TL Neural | 2480 / 6329 (39.2%) | 2985 / 63290 (4.7%) | −324.0 | −324.0 | 8.31 |
| 5-mC SRX882965 | LNCAP Prostate | 1592 / 6329 (25.2%) | 4313 / 63290 (6.8%) | −324.0 | −324.0 | 3.69 |
| 5-mC SRX882970 | LNCAP Prostate | 1926 / 6329 (30.4%) | 5632 / 63290 (8.9%) | −324.0 | −324.0 | 3.42 |
| 5-mC SRX882968 | LNCAP Prostate | 1898 / 6329 (30.0%) | 5579 / 63290 (8.8%) | −324.0 | −324.0 | 3.40 |
| RUNX1 SRX2513054 | 293 Kidney | 2055 / 6329 (32.5%) | 6712 / 63290 (10.6%) | −324.0 | −324.0 | 3.06 |
| CIC SRX13262055 | Astrocytes Neural | 1804 / 6329 (28.5%) | 6306 / 63290 (10.0%) | −324.0 | −324.0 | 2.86 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1319 / 6329 (20.8%) | 3688 / 63290 (5.8%) | −305.9 | −302.8 | 3.58 |
| AGO2 SRX4708039 | Hep G2 Liver | 1152 / 6329 (18.2%) | 2834 / 63290 (4.5%) | −303.9 | −300.7 | 4.06 |
| SREBF2 SRX5359048 | HCC70 Breast | 1082 / 6329 (17.1%) | 2838 / 63290 (4.5%) | −264.8 | −261.7 | 3.81 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1143 / 6329 (18.1%) | 3182 / 63290 (5.0%) | −262.6 | −259.5 | 3.59 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1067 / 6329 (16.9%) | 2928 / 63290 (4.6%) | −247.7 | −244.7 | 3.64 |
| BMI1 SRX7196721 | SF8628 Neural | 1062 / 6329 (16.8%) | 2929 / 63290 (4.6%) | −245.0 | −242.0 | 3.63 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 686 / 6329 (10.8%) | 1178 / 63290 (1.9%) | −242.8 | −239.8 | 5.82 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 454 / 6329 (7.2%) | 398 / 63290 (0.6%) | −240.6 | −237.6 | 11.41 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1149 / 6329 (18.2%) | 3460 / 63290 (5.5%) | −239.8 | −236.8 | 3.32 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 859 / 6329 (13.6%) | 1959 / 63290 (3.1%) | −239.5 | −236.5 | 4.38 |
| MECOM SRX23677896 | HNT-34 Blood | 1247 / 6329 (19.7%) | 4039 / 63290 (6.4%) | −238.3 | −235.3 | 3.09 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1015 / 6329 (16.0%) | 2753 / 63290 (4.3%) | −237.9 | −234.9 | 3.69 |
| MECOM SRX23677897 | HNT-34 Blood | 1217 / 6329 (19.2%) | 3879 / 63290 (6.1%) | −237.1 | −234.2 | 3.14 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 732 / 6329 (11.6%) | 1416 / 63290 (2.2%) | −235.6 | −232.6 | 5.17 |
| RUNX1 SRX2014504 | Jurkat Blood | 1359 / 6329 (21.5%) | 4767 / 63290 (7.5%) | −234.1 | −231.1 | 2.85 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1127 / 6329 (17.8%) | 3412 / 63290 (5.4%) | −233.2 | −230.2 | 3.30 |
| TRP47 SRX4548329 | THP-1 Blood | 1437 / 6329 (22.7%) | 5291 / 63290 (8.4%) | −231.3 | −228.4 | 2.72 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1083 / 6329 (17.1%) | 3266 / 63290 (5.2%) | −224.4 | −221.4 | 3.32 |
| MECOM SRX23677885 | HNT-34 Blood | 1044 / 6329 (16.5%) | 3078 / 63290 (4.9%) | −221.8 | −218.9 | 3.39 |
| MITF SRX1555436 | 501A Epidermis | 1140 / 6329 (18.0%) | 3623 / 63290 (5.7%) | −221.5 | −218.6 | 3.15 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1057 / 6329 (16.7%) | 3155 / 63290 (5.0%) | −221.4 | −218.5 | 3.35 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1059 / 6329 (16.7%) | 3176 / 63290 (5.0%) | −220.5 | −217.6 | 3.33 |
| Epitope tags SRX10549776 | K-562 Blood | 828 / 6329 (13.1%) | 1983 / 63290 (3.1%) | −219.2 | −216.4 | 4.18 |
| MECOM SRX23677884 | HNT-34 Blood | 1026 / 6329 (16.2%) | 3049 / 63290 (4.8%) | −215.5 | −212.7 | 3.37 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 925 / 6329 (14.6%) | 2583 / 63290 (4.1%) | −208.1 | −205.2 | 3.58 |
| PBX4 SRX2731658 | PC-3 Prostate | 213 / 6329 (3.4%) | 9836 / 63290 (15.5%) | −202.9 | −200.1 | 0.22 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 350 / 6329 (5.5%) | 255 / 63290 (0.4%) | −201.0 | −198.1 | 13.73 |
| RORC SRX5359052 | HCC70 Breast | 788 / 6329 (12.5%) | 1967 / 63290 (3.1%) | −199.2 | −196.4 | 4.01 |
| FOXP1 SRX736067 | LNCAP Prostate | 472 / 6329 (7.5%) | 632 / 63290 (1.0%) | −197.3 | −194.5 | 7.47 |
| ERG SRX063922 | K-562 Blood | 912 / 6329 (14.4%) | 2650 / 63290 (4.2%) | −195.3 | −192.5 | 3.44 |
| AGO2 SRX6783957 | Hep G2 Liver | 705 / 6329 (11.1%) | 1695 / 63290 (2.7%) | −184.4 | −181.6 | 4.16 |
| RORC SRX5359053 | HCC70 Breast | 740 / 6329 (11.7%) | 1872 / 63290 (3.0%) | −183.8 | −181.0 | 3.95 |
| TET2 SRX2014505 | Jurkat Blood | 1351 / 6329 (21.3%) | 5531 / 63290 (8.7%) | −180.1 | −177.3 | 2.44 |
| IRF3 SRX11453858 | Hep G2 Liver | 218 / 6329 (3.4%) | 47 / 63290 (0.1%) | −177.8 | −175.0 | 46.38 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 339 / 6329 (5.4%) | 302 / 63290 (0.5%) | −177.5 | −174.8 | 11.23 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 764 / 6329 (12.1%) | 2069 / 63290 (3.3%) | −176.0 | −173.3 | 3.69 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 922 / 6329 (14.6%) | 2955 / 63290 (4.7%) | −173.9 | −171.1 | 3.12 |
| ERG SRX063921 | K-562 Blood | 834 / 6329 (13.2%) | 2465 / 63290 (3.9%) | −173.7 | −171.0 | 3.38 |
| AGO2 SRX6783958 | Hep G2 Liver | 670 / 6329 (10.6%) | 1626 / 63290 (2.6%) | −173.1 | −170.4 | 4.12 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 996 / 6329 (15.7%) | 3437 / 63290 (5.4%) | −170.0 | −167.3 | 2.90 |
| ZFX SRX7805372 | 293 Kidney | 863 / 6329 (13.6%) | 2671 / 63290 (4.2%) | −169.8 | −167.0 | 3.23 |
| MECOM SRX23677890 | HNT-34 Blood | 966 / 6329 (15.3%) | 3282 / 63290 (5.2%) | −168.2 | −165.4 | 2.94 |
| TP53 SRX19538279 | Osteoblasts Bone | 262 / 6329 (4.1%) | 143 / 63290 (0.2%) | −167.8 | −165.1 | 18.32 |
| Epitope tags SRX2867680 | 293 Kidney | 1083 / 6329 (17.1%) | 4008 / 63290 (6.3%) | −167.2 | −164.5 | 2.70 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 358 / 6329 (5.7%) | 405 / 63290 (0.6%) | −165.2 | −162.5 | 8.84 |
| MECOM SRX23677891 | HNT-34 Blood | 950 / 6329 (15.0%) | 3233 / 63290 (5.1%) | −164.9 | −162.2 | 2.94 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 888 / 6329 (14.0%) | 2873 / 63290 (4.5%) | −164.8 | −162.1 | 3.09 |
| SREBF2 SRX5359049 | HCC70 Breast | 681 / 6329 (10.8%) | 1777 / 63290 (2.8%) | −162.7 | −160.1 | 3.83 |
| FOS SRX150477 | MCF 10A Breast | 139 / 6329 (2.2%) | 7357 / 63290 (11.6%) | −162.1 | −159.4 | 0.19 |
| FOS SRX150478 | MCF 10A Breast | 153 / 6329 (2.4%) | 7553 / 63290 (11.9%) | −159.2 | −156.5 | 0.20 |
| CTCF SRX10975999 | NALM-6 Blood | 1510 / 6329 (23.9%) | 7029 / 63290 (11.1%) | −158.9 | −156.3 | 2.15 |
| Epitope tags SRX2255894 | 293 Kidney | 745 / 6329 (11.8%) | 2151 / 63290 (3.4%) | −158.7 | −156.1 | 3.46 |
| IRF3 SRX11453861 | Hep G2 Liver | 191 / 6329 (3.0%) | 45 / 63290 (0.1%) | −153.1 | −150.5 | 42.44 |
| TP53 SRX19538280 | Osteoblasts Bone | 225 / 6329 (3.6%) | 104 / 63290 (0.2%) | −152.2 | −149.6 | 21.63 |
| TP53 SRX19538268 | U2OS Bone | 218 / 6329 (3.4%) | 95 / 63290 (0.2%) | −150.2 | −147.5 | 22.95 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 330 / 6329 (5.2%) | 384 / 63290 (0.6%) | −149.7 | −147.1 | 8.59 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1022 / 6329 (16.1%) | 3895 / 63290 (6.2%) | −149.5 | −146.9 | 2.62 |
| Epitope tags SRX9005596 | TM5 Others | 1875 / 6329 (29.6%) | 9991 / 63290 (15.8%) | −149.2 | −146.6 | 1.88 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 960 / 6329 (15.2%) | 3541 / 63290 (5.6%) | −147.4 | −144.8 | 2.71 |
| RBFOX2 SRX4708082 | K-562 Blood | 1136 / 6329 (17.9%) | 4679 / 63290 (7.4%) | −146.7 | −144.1 | 2.43 |
| BRD4 SRX736204 | 90-8TL Neural | 507 / 6329 (8.0%) | 1095 / 63290 (1.7%) | −145.7 | −143.1 | 4.63 |
| TP53 SRX19538274 | U2OS Bone | 213 / 6329 (3.4%) | 97 / 63290 (0.2%) | −144.8 | −142.2 | 21.96 |
| FOS SRX4192880 | MCF 10A Breast | 96 / 6329 (1.5%) | 5991 / 63290 (9.5%) | −143.1 | −140.5 | 0.16 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1117 / 6329 (17.6%) | 4617 / 63290 (7.3%) | −142.9 | −140.4 | 2.42 |
| TP53 SRX19538281 | Osteoblasts Bone | 228 / 6329 (3.6%) | 137 / 63290 (0.2%) | −141.0 | −138.4 | 16.64 |
| TP53 SRX19538276 | U2OS Bone | 214 / 6329 (3.4%) | 109 / 63290 (0.2%) | −140.3 | −137.7 | 19.63 |
| TP53 SRX19538273 | U2OS Bone | 202 / 6329 (3.2%) | 89 / 63290 (0.1%) | −138.7 | −136.1 | 22.70 |
| TP53 SRX19538275 | U2OS Bone | 207 / 6329 (3.3%) | 99 / 63290 (0.2%) | −138.5 | −136.0 | 20.91 |
| YAP1 SRX757325 | H2052 Lung | 194 / 6329 (3.1%) | 7708 / 63290 (12.2%) | −138.2 | −135.6 | 0.25 |
| MethylCap SRX014767 | NB-4 Blood | 868 / 6329 (13.7%) | 3117 / 63290 (4.9%) | −137.9 | −135.3 | 2.78 |
| CHD6 SRX17709200 | C4-2 Prostate | 800 / 6329 (12.6%) | 2719 / 63290 (4.3%) | −137.4 | −134.9 | 2.94 |
| Epitope tags SRX4892334 | 293 Kidney | 1131 / 6329 (17.9%) | 4853 / 63290 (7.7%) | −135.0 | −132.4 | 2.33 |
| GRHL3 SRX2582162 | NHEK Epidermis | 571 / 6329 (9.0%) | 1496 / 63290 (2.4%) | −134.9 | −132.3 | 3.82 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 643 / 6329 (10.2%) | 1874 / 63290 (3.0%) | −134.5 | −131.9 | 3.43 |
| Epitope tags SRX3657345 | 293 Kidney | 1127 / 6329 (17.8%) | 4857 / 63290 (7.7%) | −133.3 | −130.8 | 2.32 |
| TP53 SRX19538269 | U2OS Bone | 242 / 6329 (3.8%) | 193 / 63290 (0.3%) | −133.2 | −130.7 | 12.54 |
| KLF4 SRX12144701 | T/C28a2 Bone | 1278 / 6329 (20.2%) | 5934 / 63290 (9.4%) | −131.8 | −129.3 | 2.15 |
| TP53 SRX19538267 | U2OS Bone | 193 / 6329 (3.0%) | 87 / 63290 (0.1%) | −131.6 | −129.1 | 22.18 |
| YAP1 SRX757326 | H2052 Lung | 162 / 6329 (2.6%) | 6899 / 63290 (10.9%) | −129.6 | −127.1 | 0.23 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 346 / 6329 (5.5%) | 543 / 63290 (0.9%) | −128.9 | −126.4 | 6.37 |
| SUZ12 SRX10184494 | K-562 Blood | 1166 / 6329 (18.4%) | 5213 / 63290 (8.2%) | −128.7 | −126.2 | 2.24 |
| Epitope tags SRX10549777 | K-562 Blood | 1120 / 6329 (17.7%) | 4921 / 63290 (7.8%) | −127.5 | −125.0 | 2.28 |
| TP53 SRX19538270 | U2OS Bone | 233 / 6329 (3.7%) | 195 / 63290 (0.3%) | −125.4 | −122.9 | 11.95 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 202 / 6329 (3.2%) | 121 / 63290 (0.2%) | −125.0 | −122.5 | 16.69 |
| Epitope tags SRX10549778 | K-562 Blood | 561 / 6329 (8.9%) | 1569 / 63290 (2.5%) | −122.7 | −120.2 | 3.58 |
| KAT6A SRX20971022 | Fibroblasts Others | 156 / 6329 (2.5%) | 41 / 63290 (0.1%) | −122.3 | −119.8 | 38.05 |
| GRHL3 SRX2582161 | NHEK Epidermis | 483 / 6329 (7.6%) | 1204 / 63290 (1.9%) | −119.9 | −117.4 | 4.01 |
| BCOR SRX10184493 | K-562 Blood | 1011 / 6329 (16.0%) | 4343 / 63290 (6.9%) | −119.1 | −116.6 | 2.33 |
| CHD6 SRX17709201 | C4-2 Prostate | 733 / 6329 (11.6%) | 2582 / 63290 (4.1%) | −118.5 | −116.0 | 2.84 |
| BRPF3 SRX796085 | RKO Digestive tract | 512 / 6329 (8.1%) | 1392 / 63290 (2.2%) | −115.5 | −113.0 | 3.68 |
| AR SRX10820653 | LNCAP Prostate | 182 / 6329 (2.9%) | 102 / 63290 (0.2%) | −115.4 | −113.0 | 17.84 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 194 / 6329 (3.1%) | 7013 / 63290 (11.1%) | −114.5 | −112.0 | 0.28 |
| MYH11 SRX265221 | ME-1 Blood | 263 / 6329 (4.2%) | 331 / 63290 (0.5%) | −113.6 | −111.1 | 7.95 |
| CBFB SRX265218 | ME-1 Blood | 701 / 6329 (11.1%) | 2465 / 63290 (3.9%) | −113.5 | −111.0 | 2.84 |
| CTCF SRX10976007 | NALM-6 Blood | 1151 / 6329 (18.2%) | 5426 / 63290 (8.6%) | −113.3 | −110.8 | 2.12 |
| KLF4 SRX12144702 | T/C28a2 Bone | 1120 / 6329 (17.7%) | 5205 / 63290 (8.2%) | −113.3 | −110.8 | 2.15 |
| CTCF SRX10976001 | NALM-6 Blood | 1135 / 6329 (17.9%) | 5318 / 63290 (8.4%) | −113.0 | −110.6 | 2.13 |
| CTCF SRX10976000 | NALM-6 Blood | 1269 / 6329 (20.1%) | 6292 / 63290 (9.9%) | −112.5 | −110.1 | 2.02 |
| PHF6 SRX11508321 | G-401 Kidney | 724 / 6329 (11.4%) | 2619 / 63290 (4.1%) | −112.4 | −110.0 | 2.76 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 854 / 6329 (13.5%) | 3439 / 63290 (5.4%) | −111.8 | −109.4 | 2.48 |
| FOS SRX150476 | MCF 10A Breast | 142 / 6329 (2.2%) | 6014 / 63290 (9.5%) | −111.6 | −109.2 | 0.24 |
| Epitope tags SRX667413 | MCF-7 Breast | 881 / 6329 (13.9%) | 3623 / 63290 (5.7%) | −111.4 | −109.0 | 2.43 |
| BRPF3 SRX796084 | RKO Digestive tract | 678 / 6329 (10.7%) | 2365 / 63290 (3.7%) | −111.0 | −108.5 | 2.87 |
| BCORL1 SRX10184496 | K-562 Blood | 919 / 6329 (14.5%) | 3882 / 63290 (6.1%) | −110.8 | −108.4 | 2.37 |
| BMI1 SRX8726297 | Tumor Others | 736 / 6329 (11.6%) | 2731 / 63290 (4.3%) | −109.8 | −107.4 | 2.69 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 722 / 6329 (11.4%) | 2648 / 63290 (4.2%) | −109.6 | −107.2 | 2.73 |
| CDK9 SRX20230570 | Ishikawa Uterus | 775 / 6329 (12.2%) | 2996 / 63290 (4.7%) | −108.2 | −105.8 | 2.59 |
| FOXA1 SRX4815198 | MCF-7 Breast | 336 / 6329 (5.3%) | 9055 / 63290 (14.3%) | −108.0 | −105.6 | 0.37 |
| ASCL1 SRX8949802 | Unclassified Unclassified | 812 / 6329 (12.8%) | 3236 / 63290 (5.1%) | −107.9 | −105.5 | 2.51 |
| NABP2 SRX9523535 | HT-1080 Bone | 650 / 6329 (10.3%) | 2245 / 63290 (3.5%) | −107.8 | −105.4 | 2.90 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 730 / 6329 (11.5%) | 2725 / 63290 (4.3%) | −107.6 | −105.2 | 2.68 |
| FOS SRX150517 | MCF 10A Breast | 149 / 6329 (2.4%) | 6016 / 63290 (9.5%) | −107.4 | −105.0 | 0.25 |
| CDK9 SRX20230567 | Ishikawa Uterus | 807 / 6329 (12.8%) | 3218 / 63290 (5.1%) | −107.1 | −104.7 | 2.51 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 766 / 6329 (12.1%) | 2972 / 63290 (4.7%) | −106.4 | −104.0 | 2.58 |
| FOXA1 SRX4815197 | MCF-7 Breast | 236 / 6329 (3.7%) | 7433 / 63290 (11.7%) | −105.7 | −103.3 | 0.32 |
| KMT2A SRX2281249 | SEM Blood | 876 / 6329 (13.8%) | 3692 / 63290 (5.8%) | −105.6 | −103.3 | 2.37 |
| DDX21 SRX8257415 | A-375 Epidermis | 460 / 6329 (7.3%) | 1229 / 63290 (1.9%) | −105.6 | −103.2 | 3.74 |
| BRD1 SRX286203 | RKO Digestive tract | 528 / 6329 (8.3%) | 1585 / 63290 (2.5%) | −105.5 | −103.2 | 3.33 |
| BRPF3 SRX796086 | RKO Digestive tract | 646 / 6329 (10.2%) | 2254 / 63290 (3.6%) | −105.4 | −103.0 | 2.87 |
| TP53 SRX19538282 | Osteoblasts Bone | 190 / 6329 (3.0%) | 149 / 63290 (0.2%) | −105.4 | −103.0 | 12.75 |
| BCORL1 SRX10184498 | K-562 Blood | 937 / 6329 (14.8%) | 4109 / 63290 (6.5%) | −105.1 | −102.8 | 2.28 |
| ZFX SRX7805370 | 293 Kidney | 554 / 6329 (8.8%) | 1754 / 63290 (2.8%) | −103.4 | −101.0 | 3.16 |
| TET1 SRX10382426 | hESC H1 Pluripotent stem cell | 1052 / 6329 (16.6%) | 4945 / 63290 (7.8%) | −103.2 | −100.8 | 2.13 |
| BCORL1 SRX10184497 | K-562 Blood | 906 / 6329 (14.3%) | 3939 / 63290 (6.2%) | −103.1 | −100.8 | 2.30 |
| TP53 SRX19538271 | U2OS Bone | 294 / 6329 (4.6%) | 500 / 63290 (0.8%) | −102.9 | −100.6 | 5.88 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 386 / 6329 (6.1%) | 900 / 63290 (1.4%) | −102.3 | −100.0 | 4.29 |
| SS18L1 SRX10881821 | G-401 Kidney | 886 / 6329 (14.0%) | 3838 / 63290 (6.1%) | −101.5 | −99.1 | 2.31 |
| Epitope tags SRX2255895 | 293 Kidney | 467 / 6329 (7.4%) | 1308 / 63290 (2.1%) | −101.4 | −99.1 | 3.57 |
| FOXA1 SRX3931044 | MCF-7 Breast | 207 / 6329 (3.3%) | 6821 / 63290 (10.8%) | −101.2 | −98.8 | 0.30 |
| FOXA1 SRX176862 | MCF-7 Breast | 113 / 6329 (1.8%) | 5177 / 63290 (8.2%) | −101.0 | −98.7 | 0.22 |
| CTCF SRX10976002 | NALM-6 Blood | 1238 / 6329 (19.6%) | 6350 / 63290 (10.0%) | −100.7 | −98.4 | 1.95 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 652 / 6329 (10.3%) | 2368 / 63290 (3.7%) | −100.1 | −97.7 | 2.75 |
| CDK9 SRX20230573 | Ishikawa Uterus | 942 / 6329 (14.9%) | 4254 / 63290 (6.7%) | −99.6 | −97.3 | 2.21 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 169 / 6329 (2.7%) | 115 / 63290 (0.2%) | −99.6 | −97.2 | 14.70 |
| KMT2A SRX1293531 | MV-4-11 Blood | 1085 / 6329 (17.1%) | 5260 / 63290 (8.3%) | −99.5 | −97.2 | 2.06 |
| KAT7 SRX101303 | RKO Digestive tract | 586 / 6329 (9.3%) | 1985 / 63290 (3.1%) | −99.5 | −97.2 | 2.95 |
| ASCL1 SRX8949803 | Unclassified Unclassified | 845 / 6329 (13.4%) | 3606 / 63290 (5.7%) | −99.1 | −96.8 | 2.34 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 674 / 6329 (10.6%) | 2514 / 63290 (4.0%) | −99.1 | −96.8 | 2.68 |
| LARP7 SRX2198835 | HeLa Uterus | 908 / 6329 (14.3%) | 4034 / 63290 (6.4%) | −99.0 | −96.7 | 2.25 |
| MCM3 SRX9107920 | hTERT RPE-1 Neural | 444 / 6329 (7.0%) | 1218 / 63290 (1.9%) | −98.7 | −96.4 | 3.65 |
| RBFOX2 SRX3322781 | K-562 Blood | 868 / 6329 (13.7%) | 3795 / 63290 (6.0%) | −97.4 | −95.1 | 2.29 |
| Epitope tags SRX7276677 | 293 Kidney | 1137 / 6329 (18.0%) | 5690 / 63290 (9.0%) | −97.2 | −94.9 | 2.00 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 662 / 6329 (10.5%) | 2472 / 63290 (3.9%) | −97.2 | −94.9 | 2.68 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 610 / 6329 (9.6%) | 2169 / 63290 (3.4%) | −96.5 | −94.2 | 2.81 |
| AR SRX10820651 | LNCAP Prostate | 180 / 6329 (2.8%) | 154 / 63290 (0.2%) | −95.9 | −93.6 | 11.69 |
| RBFOX2 SRX3322782 | K-562 Blood | 819 / 6329 (12.9%) | 3503 / 63290 (5.5%) | −95.6 | −93.3 | 2.34 |
| Epitope tags SRX15725652 | 293 Kidney | 807 / 6329 (12.8%) | 3425 / 63290 (5.4%) | −95.5 | −93.2 | 2.36 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 793 / 6329 (12.5%) | 3337 / 63290 (5.3%) | −95.2 | −92.9 | 2.38 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 302 / 6329 (4.8%) | 584 / 63290 (0.9%) | −95.1 | −92.9 | 5.17 |
| BMI1 SRX644729 | 293 Kidney | 144 / 6329 (2.3%) | 72 / 63290 (0.1%) | −95.0 | −92.8 | 20.00 |
| MEAF6 DRX234811 | 293 Kidney | 723 / 6329 (11.4%) | 2908 / 63290 (4.6%) | −93.8 | −91.5 | 2.49 |
| Epitope tags SRX12024485 | Polycystic kidney Kidney | 1104 / 6329 (17.4%) | 5542 / 63290 (8.8%) | −93.3 | −91.1 | 1.99 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 266 / 6329 (4.2%) | 455 / 63290 (0.7%) | −92.7 | −90.4 | 5.85 |
| ESR1 SRX2901942 | Ishikawa Uterus | 536 / 6329 (8.5%) | 1791 / 63290 (2.8%) | −92.6 | −90.3 | 2.99 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 132 / 6329 (2.1%) | 55 / 63290 (0.1%) | −92.2 | −89.9 | 24.00 |
| PHF6 SRX11508322 | G-401 Kidney | 417 / 6329 (6.6%) | 1151 / 63290 (1.8%) | −91.9 | −89.7 | 3.62 |
| FOS SRX4192879 | MCF 10A Breast | 101 / 6329 (1.6%) | 4675 / 63290 (7.4%) | −91.5 | −89.3 | 0.22 |
| JUN SRX4192884 | MCF 10A Breast | 65 / 6329 (1.0%) | 3951 / 63290 (6.2%) | −91.3 | −89.1 | 0.16 |
| CTCF SRX12008354 | MCF 10A Breast | 1601 / 6329 (25.3%) | 9437 / 63290 (14.9%) | −91.2 | −89.0 | 1.70 |
| FOXA1 SRX176863 | MCF-7 Breast | 113 / 6329 (1.8%) | 4891 / 63290 (7.7%) | −91.2 | −89.0 | 0.23 |
| Epitope tags SRX3657349 | 293 Kidney | 1737 / 6329 (27.4%) | 10550 / 63290 (16.7%) | −91.1 | −88.8 | 1.65 |
| Epitope tags SRX15725650 | 293 Kidney | 722 / 6329 (11.4%) | 2953 / 63290 (4.7%) | −90.9 | −88.7 | 2.44 |
| KAT6A DRX366108 | 293 Kidney | 748 / 6329 (11.8%) | 3124 / 63290 (4.9%) | −90.7 | −88.5 | 2.39 |
| CTCF SRX10976009 | 697 Blood | 982 / 6329 (15.5%) | 4726 / 63290 (7.5%) | −90.6 | −88.4 | 2.08 |
| GATA3 SRX176864 | MCF-7 Breast | 58 / 6329 (0.9%) | 3776 / 63290 (6.0%) | −90.5 | −88.2 | 0.15 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 473 / 6329 (7.5%) | 1467 / 63290 (2.3%) | −90.3 | −88.1 | 3.22 |
| Epitope tags SRX4892338 | 293 Kidney | 1733 / 6329 (27.4%) | 10550 / 63290 (16.7%) | −90.2 | −87.9 | 1.64 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 385 / 6329 (6.1%) | 9133 / 63290 (14.4%) | −89.9 | −87.7 | 0.42 |
| LEO1 SRX1873456 | SEM Blood | 625 / 6329 (9.9%) | 2359 / 63290 (3.7%) | −89.8 | −87.6 | 2.65 |
| CDK9 SRX20230574 | Ishikawa Uterus | 647 / 6329 (10.2%) | 2499 / 63290 (3.9%) | −89.6 | −87.4 | 2.59 |
| TET2 SRX1427029 | 293 Kidney | 569 / 6329 (9.0%) | 2025 / 63290 (3.2%) | −89.6 | −87.3 | 2.81 |
| MethylCap SRX014766 | NB-4 Blood | 684 / 6329 (10.8%) | 2742 / 63290 (4.3%) | −89.0 | −86.7 | 2.49 |
| MethylCap SRX026646 | Acute myeloid leukemia Blood | 314 / 6329 (5.0%) | 683 / 63290 (1.1%) | −88.9 | −86.7 | 4.60 |
| CTCF SRX12008351 | MCF 10A Breast | 1191 / 6329 (18.8%) | 6309 / 63290 (10.0%) | −88.6 | −86.3 | 1.89 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 693 / 6329 (10.9%) | 2810 / 63290 (4.4%) | −88.5 | −86.3 | 2.47 |
| JUNB SRX4192882 | MCF 10A Breast | 63 / 6329 (1.0%) | 3818 / 63290 (6.0%) | −88.0 | −85.8 | 0.17 |
| KAT6A DRX366109 | 293 Kidney | 880 / 6329 (13.9%) | 4067 / 63290 (6.4%) | −87.9 | −85.7 | 2.16 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 682 / 6329 (10.8%) | 2762 / 63290 (4.4%) | −87.2 | −85.0 | 2.47 |
| CTCF SRX10976008 | NALM-6 Blood | 1048 / 6329 (16.6%) | 5289 / 63290 (8.4%) | −86.9 | −84.7 | 1.98 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 124 / 6329 (2.0%) | 4958 / 63290 (7.8%) | −86.8 | −84.6 | 0.25 |
| KAT6B DRX411443 | 293 Kidney | 904 / 6329 (14.3%) | 4264 / 63290 (6.7%) | −86.7 | −84.5 | 2.12 |
| ESR1 SRX2578880 | MDA-MB-231 Breast | 608 / 6329 (9.6%) | 2306 / 63290 (3.6%) | −86.6 | −84.4 | 2.64 |
| GTF3C1 SRX4636577 | 293 Kidney | 586 / 6329 (9.3%) | 2171 / 63290 (3.4%) | −86.5 | −84.3 | 2.70 |
| TET2 SRX2513053 | Jurkat Blood | 890 / 6329 (14.1%) | 4168 / 63290 (6.6%) | −86.5 | −84.3 | 2.14 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 542 / 6329 (8.6%) | 1914 / 63290 (3.0%) | −86.3 | −84.1 | 2.83 |
| MEAF6 DRX300417 | 293 Kidney | 651 / 6329 (10.3%) | 2593 / 63290 (4.1%) | −85.5 | −83.3 | 2.51 |
| TLE3 SRX4815191 | MCF-7 Breast | 92 / 6329 (1.5%) | 4325 / 63290 (6.8%) | −85.4 | −83.2 | 0.21 |
| GATA3 SRX190239 | MCF-7 Breast | 155 / 6329 (2.4%) | 5452 / 63290 (8.6%) | −85.3 | −83.1 | 0.28 |
| FOXA2 SRX3644342 | BJ Epidermis | 147 / 6329 (2.3%) | 5312 / 63290 (8.4%) | −85.3 | −83.1 | 0.28 |
| ASCL1 SRX8949797 | Unclassified Unclassified | 863 / 6329 (13.6%) | 4010 / 63290 (6.3%) | −85.2 | −83.0 | 2.15 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 245 / 6329 (3.9%) | 6891 / 63290 (10.9%) | −84.8 | −82.6 | 0.36 |
| Epitope tags SRX1457740 | 293 Kidney | 417 / 6329 (6.6%) | 1232 / 63290 (1.9%) | −84.6 | −82.4 | 3.38 |
| MYOCD SRX5598318 | A549 Lung | 724 / 6329 (11.4%) | 3085 / 63290 (4.9%) | −84.4 | −82.2 | 2.35 |
| ERG SRX063918 | MCF-7 Breast | 641 / 6329 (10.1%) | 2550 / 63290 (4.0%) | −84.3 | −82.2 | 2.51 |
| TET1 SRX10382404 | hESC H1 Pluripotent stem cell | 988 / 6329 (15.6%) | 4924 / 63290 (7.8%) | −84.0 | −81.8 | 2.01 |
| JUNB SRX10119386 | MCF 10A Breast | 83 / 6329 (1.3%) | 4092 / 63290 (6.5%) | −83.4 | −81.2 | 0.20 |
| SUZ12 SRX10184495 | K-562 Blood | 845 / 6329 (13.4%) | 3935 / 63290 (6.2%) | −82.9 | −80.7 | 2.15 |
| FOXA1 SRX371482 | MCF-7 Breast | 158 / 6329 (2.5%) | 5419 / 63290 (8.6%) | −82.7 | −80.5 | 0.29 |
| FOXA1 SRX1161177 | MCF-7 Breast | 100 / 6329 (1.6%) | 4398 / 63290 (6.9%) | −82.7 | −80.5 | 0.23 |
| RBM22 SRX4708083 | K-562 Blood | 413 / 6329 (6.5%) | 1235 / 63290 (2.0%) | −82.5 | −80.3 | 3.34 |
| GATA3 SRX190194 | SK-N-SH Neural | 277 / 6329 (4.4%) | 7289 / 63290 (11.5%) | −82.4 | −80.2 | 0.38 |
| KAT6B DRX411444 | 293 Kidney | 878 / 6329 (13.9%) | 4194 / 63290 (6.6%) | −81.7 | −79.5 | 2.09 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 123 / 6329 (1.9%) | 61 / 63290 (0.1%) | −81.5 | −79.3 | 20.16 |
| CXXC1 SRX1424886 | SEM Blood | 609 / 6329 (9.6%) | 2396 / 63290 (3.8%) | −81.4 | −79.2 | 2.54 |
| CTCF SRX10976010 | 697 Blood | 819 / 6329 (12.9%) | 3795 / 63290 (6.0%) | −81.0 | −78.9 | 2.16 |
| SSRP1 SRX3436567 | HT-1080 Bone | 190 / 6329 (3.0%) | 244 / 63290 (0.4%) | −81.0 | −78.8 | 7.79 |
| CDK9 SRX20230572 | Ishikawa Uterus | 714 / 6329 (11.3%) | 3087 / 63290 (4.9%) | −80.8 | −78.7 | 2.31 |
| PGR SRX6068069 | Endometrium Uterus | 759 / 6329 (12.0%) | 3392 / 63290 (5.4%) | −80.7 | −78.5 | 2.24 |
| BCOR SRX3256873 | hESC H1 Pluripotent stem cell | 939 / 6329 (14.8%) | 4655 / 63290 (7.4%) | −80.5 | −78.4 | 2.02 |
| PCGF1 SRX3256864 | hESC H1 Pluripotent stem cell | 892 / 6329 (14.1%) | 4316 / 63290 (6.8%) | −80.5 | −78.4 | 2.07 |
| SP1 SRX113706 | HCT 116 Digestive tract | 772 / 6329 (12.2%) | 3487 / 63290 (5.5%) | −80.3 | −78.2 | 2.21 |
| Epitope tags SRX14024876 | Mesenchymal stem cells Others | 914 / 6329 (14.4%) | 4485 / 63290 (7.1%) | −80.1 | −77.9 | 2.04 |
| SMARCA4 SRX9562887 | RH-4 Muscle | 632 / 6329 (10.0%) | 2569 / 63290 (4.1%) | −80.0 | −77.8 | 2.46 |
| FOXA1 SRX371483 | MCF-7 Breast | 127 / 6329 (2.0%) | 4800 / 63290 (7.6%) | −79.9 | −77.8 | 0.26 |
| AR SRX1067066 | LHSAR Prostate | 244 / 6329 (3.9%) | 6700 / 63290 (10.6%) | −79.8 | −77.7 | 0.36 |
| AGO1 SRX4708086 | K-562 Blood | 291 / 6329 (4.6%) | 655 / 63290 (1.0%) | −79.7 | −77.5 | 4.44 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 406 / 6329 (6.4%) | 9036 / 63290 (14.3%) | −79.4 | −77.3 | 0.45 |
| FOXA1 SRX1161173 | MCF-7 Breast | 75 / 6329 (1.2%) | 3813 / 63290 (6.0%) | −79.2 | −77.0 | 0.20 |
| TP53 SRX19538272 | U2OS Bone | 250 / 6329 (4.0%) | 482 / 63290 (0.8%) | −78.9 | −76.8 | 5.19 |
| JUN SRX17561461 | LPS141 Adipocyte | 163 / 6329 (2.6%) | 5366 / 63290 (8.5%) | −78.3 | −76.2 | 0.30 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 143 / 6329 (2.3%) | 5027 / 63290 (7.9%) | −78.2 | −76.1 | 0.28 |
| CTCF SRX12008350 | MCF 10A Breast | 1183 / 6329 (18.7%) | 6544 / 63290 (10.3%) | −77.8 | −75.7 | 1.81 |
| GATA3 SRX5057632 | MCF-7 Breast | 62 / 6329 (1.0%) | 3500 / 63290 (5.5%) | −77.2 | −75.1 | 0.18 |
| Epitope tags SRX22482468 | 293 Kidney | 556 / 6329 (8.8%) | 2144 / 63290 (3.4%) | −76.6 | −74.5 | 2.59 |
| SUZ12 SRX9281791 | 293 Kidney | 175 / 6329 (2.8%) | 216 / 63290 (0.3%) | −76.5 | −74.4 | 8.10 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 112 / 6329 (1.8%) | 4423 / 63290 (7.0%) | −76.3 | −74.2 | 0.25 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 135 / 6329 (2.1%) | 4821 / 63290 (7.6%) | −76.2 | −74.0 | 0.28 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 469 / 6329 (7.4%) | 1635 / 63290 (2.6%) | −75.8 | −73.7 | 2.87 |
| BAHCC1 SRX8449942 | Jurkat Blood | 1027 / 6329 (16.2%) | 5425 / 63290 (8.6%) | −75.6 | −73.5 | 1.89 |
| AR SRX1067067 | LHSAR Prostate | 196 / 6329 (3.1%) | 5802 / 63290 (9.2%) | −75.4 | −73.3 | 0.34 |
| FOXA1 SRX1161176 | MCF-7 Breast | 104 / 6329 (1.6%) | 4245 / 63290 (6.7%) | −75.1 | −73.0 | 0.24 |
| GFP SRX1514979 | 293 Kidney | 1097 / 6329 (17.3%) | 5964 / 63290 (9.4%) | −75.1 | −73.0 | 1.84 |
| FOXA1 SRX1787653 | MCF-7 Breast | 84 / 6329 (1.3%) | 3866 / 63290 (6.1%) | −75.0 | −72.9 | 0.22 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 289 / 6329 (4.6%) | 687 / 63290 (1.1%) | −74.9 | −72.8 | 4.21 |
| ERG SRX063920 | K-562 Blood | 388 / 6329 (6.1%) | 1194 / 63290 (1.9%) | −74.5 | −72.4 | 3.25 |
| CSTF2 SRX10722980 | U2OS Bone | 337 / 6329 (5.3%) | 926 / 63290 (1.5%) | −74.5 | −72.4 | 3.64 |
| KAT7 DRX234808 | 293 Kidney | 329 / 6329 (5.2%) | 886 / 63290 (1.4%) | −74.4 | −72.3 | 3.71 |
| HNRNPC SRX4708020 | Hep G2 Liver | 440 / 6329 (7.0%) | 1489 / 63290 (2.4%) | −74.2 | −72.0 | 2.96 |
| FOXA1 SRX3931043 | MCF-7 Breast | 108 / 6329 (1.7%) | 4285 / 63290 (6.8%) | −74.1 | −72.0 | 0.25 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 172 / 6329 (2.7%) | 5364 / 63290 (8.5%) | −73.8 | −71.7 | 0.32 |
| WAS SRX5371250 | GM11518 Blood | 472 / 6329 (7.5%) | 1684 / 63290 (2.7%) | −73.6 | −71.5 | 2.80 |
| SS18L1 SRX10881824 | G-401 Kidney | 912 / 6329 (14.4%) | 4628 / 63290 (7.3%) | −73.6 | −71.5 | 1.97 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 199 / 6329 (3.1%) | 5788 / 63290 (9.1%) | −73.6 | −71.5 | 0.34 |
| ASCL1 SRX11245139 | DMS 53 Lung | 608 / 6329 (9.6%) | 2529 / 63290 (4.0%) | −73.5 | −71.5 | 2.40 |
| CTCFL SRX1091814 | K-562 Blood | 627 / 6329 (9.9%) | 2658 / 63290 (4.2%) | −73.3 | −71.2 | 2.36 |
| NCAPH2 SRX2731517 | 293 Kidney | 551 / 6329 (8.7%) | 2171 / 63290 (3.4%) | −73.2 | −71.1 | 2.54 |
| FOXA1 SRX1161175 | MCF-7 Breast | 77 / 6329 (1.2%) | 3680 / 63290 (5.8%) | −73.1 | −71.0 | 0.21 |
| ING5 SRX286202 | RKO Digestive tract | 520 / 6329 (8.2%) | 1981 / 63290 (3.1%) | −73.0 | −70.9 | 2.62 |
| FOXL2 SRX6957431 | KGN Gonad | 286 / 6329 (4.5%) | 7084 / 63290 (11.2%) | −72.9 | −70.9 | 0.40 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 496 / 6329 (7.8%) | 1838 / 63290 (2.9%) | −72.9 | −70.8 | 2.70 |
| VGLL1 SRX24602130 | BT-20 Breast | 115 / 6329 (1.8%) | 4374 / 63290 (6.9%) | −72.8 | −70.8 | 0.26 |
| FOXA2 SRX3644356 | BJ Epidermis | 87 / 6329 (1.4%) | 3864 / 63290 (6.1%) | −72.8 | −70.8 | 0.23 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 76 / 6329 (1.2%) | 3649 / 63290 (5.8%) | −72.8 | −70.7 | 0.21 |
| GTF3C1 SRX4636578 | 293 Kidney | 549 / 6329 (8.7%) | 2168 / 63290 (3.4%) | −72.7 | −70.7 | 2.53 |
| CHD6 SRX17709202 | C4-2 Prostate | 466 / 6329 (7.4%) | 1663 / 63290 (2.6%) | −72.6 | −70.6 | 2.80 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 112 / 6329 (1.8%) | 4306 / 63290 (6.8%) | −72.4 | −70.3 | 0.26 |
| CBX7 SRX6370188 | NT2-D1 Pluripotent stem cell | 254 / 6329 (4.0%) | 548 / 63290 (0.9%) | −72.4 | −70.3 | 4.64 |
| Epitope tags DRX443510 | 293 Kidney | 585 / 6329 (9.2%) | 2402 / 63290 (3.8%) | −72.3 | −70.3 | 2.44 |
| STAT5B SRX831881 | CD8+ T cells Blood | 116 / 6329 (1.8%) | 69 / 63290 (0.1%) | −72.2 | −70.1 | 16.81 |
| ZNF711 SRX7805363 | 293 Kidney | 624 / 6329 (9.9%) | 2665 / 63290 (4.2%) | −71.8 | −69.8 | 2.34 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 140 / 6329 (2.2%) | 4762 / 63290 (7.5%) | −71.6 | −69.5 | 0.29 |
| JUNB SRX10119383 | MCF 10A Breast | 68 / 6329 (1.1%) | 3459 / 63290 (5.5%) | −71.6 | −69.5 | 0.20 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 147 / 6329 (2.3%) | 4881 / 63290 (7.7%) | −71.6 | −69.5 | 0.30 |
| KDM2B SRX3256862 | hESC H1 Pluripotent stem cell | 983 / 6329 (15.5%) | 5204 / 63290 (8.2%) | −71.5 | −69.5 | 1.89 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 123 / 6329 (1.9%) | 4468 / 63290 (7.1%) | −71.5 | −69.4 | 0.28 |
| FOXA1 SRX371481 | MCF-7 Breast | 129 / 6329 (2.0%) | 4569 / 63290 (7.2%) | −71.4 | −69.3 | 0.28 |
| Epitope tags SRX8030771 | 293 Kidney | 657 / 6329 (10.4%) | 2895 / 63290 (4.6%) | −71.3 | −69.2 | 2.27 |
| AR SRX1067071 | LHSAR Prostate | 247 / 6329 (3.9%) | 6448 / 63290 (10.2%) | −71.3 | −69.2 | 0.38 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 98 / 6329 (1.5%) | 4019 / 63290 (6.4%) | −71.3 | −69.2 | 0.24 |
| DMC1 SRX663450 | Testis Gonad | 259 / 6329 (4.1%) | 580 / 63290 (0.9%) | −71.2 | −69.2 | 4.47 |
| JUNB SRX8488088 | SUM 229PE Breast | 241 / 6329 (3.8%) | 6354 / 63290 (10.0%) | −71.2 | −69.1 | 0.38 |
| CDT1 SRX10644243 | HCT 116 Digestive tract | 650 / 6329 (10.3%) | 2855 / 63290 (4.5%) | −71.0 | −68.9 | 2.28 |
| TFAP2A SRX20744801 | GP5d Digestive tract | 410 / 6329 (6.5%) | 1362 / 63290 (2.2%) | −70.9 | −68.9 | 3.01 |
| RAC1 SRX10365541 | MCF-7 Breast | 52 / 6329 (0.8%) | 3116 / 63290 (4.9%) | −70.9 | −68.9 | 0.17 |
| RNF2 SRX9555210 | 293 Kidney | 157 / 6329 (2.5%) | 184 / 63290 (0.3%) | −70.8 | −68.8 | 8.53 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 106 / 6329 (1.7%) | 4150 / 63290 (6.6%) | −70.8 | −68.7 | 0.26 |
| ESR1 SRX371476 | MCF-7 Breast | 85 / 6329 (1.3%) | 3762 / 63290 (5.9%) | −70.7 | −68.7 | 0.23 |
| JUNB SRX10119384 | MCF 10A Breast | 62 / 6329 (1.0%) | 3315 / 63290 (5.2%) | −70.7 | −68.6 | 0.19 |
| G3BP1 SRX24196609 | KGN Gonad | 653 / 6329 (10.3%) | 2883 / 63290 (4.6%) | −70.6 | −68.5 | 2.27 |
| HDAC1 SRX17989501 | PBMC Blood | 822 / 6329 (13.0%) | 4051 / 63290 (6.4%) | −70.6 | −68.5 | 2.03 |
| ZBTB26 SRX3322067 | 293 Kidney | 768 / 6329 (12.1%) | 3673 / 63290 (5.8%) | −70.5 | −68.4 | 2.09 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 245 / 6329 (3.9%) | 525 / 63290 (0.8%) | −70.3 | −68.2 | 4.67 |
| RNF2 SRX9555214 | 293 Kidney | 161 / 6329 (2.5%) | 200 / 63290 (0.3%) | −70.1 | −68.1 | 8.05 |
| SUZ12 SRX4650934 | 293 Kidney | 146 / 6329 (2.3%) | 154 / 63290 (0.2%) | −70.0 | −67.9 | 9.48 |
| EP300 SRX150579 | HeLa Uterus | 67 / 6329 (1.1%) | 3393 / 63290 (5.4%) | −69.9 | −67.9 | 0.20 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 306 / 6329 (4.8%) | 7261 / 63290 (11.5%) | −69.9 | −67.9 | 0.42 |
| FOXA1 SRX3931054 | MCF-7 Breast | 105 / 6329 (1.7%) | 4099 / 63290 (6.5%) | −69.8 | −67.8 | 0.26 |
| RNF2 SRX9555213 | 293 Kidney | 157 / 6329 (2.5%) | 190 / 63290 (0.3%) | −69.5 | −67.5 | 8.26 |
| YAP1 SRX10119364 | MCF 10A Breast | 97 / 6329 (1.5%) | 3942 / 63290 (6.2%) | −69.4 | −67.3 | 0.25 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 89 / 6329 (1.4%) | 3794 / 63290 (6.0%) | −69.3 | −67.3 | 0.23 |
| SUZ12 SRX4650953 | 293 Kidney | 148 / 6329 (2.3%) | 163 / 63290 (0.3%) | −69.2 | −67.2 | 9.08 |
| ING2 SRX286201 | RKO Digestive tract | 562 / 6329 (8.9%) | 2312 / 63290 (3.7%) | −69.1 | −67.1 | 2.43 |
| ESR1 SRX371478 | MCF-7 Breast | 166 / 6329 (2.6%) | 5112 / 63290 (8.1%) | −69.1 | −67.1 | 0.32 |
| RNF2 SRX9555212 | 293 Kidney | 155 / 6329 (2.4%) | 186 / 63290 (0.3%) | −69.0 | −66.9 | 8.33 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 107 / 6329 (1.7%) | 4110 / 63290 (6.5%) | −68.9 | −66.9 | 0.26 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 424 / 6329 (6.7%) | 1471 / 63290 (2.3%) | −68.9 | −66.9 | 2.88 |
| CNOT3 SRX886388 | Colorectal carcinoma Digestive tract | 762 / 6329 (12.0%) | 3669 / 63290 (5.8%) | −68.9 | −66.8 | 2.08 |
| AR SRX1067068 | LHSAR Prostate | 139 / 6329 (2.2%) | 4654 / 63290 (7.4%) | −68.7 | −66.7 | 0.30 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 271 / 6329 (4.3%) | 6705 / 63290 (10.6%) | −68.6 | −66.6 | 0.40 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 111 / 6329 (1.8%) | 4169 / 63290 (6.6%) | −68.6 | −66.6 | 0.27 |
| EP300 SRX2671813 | Fibroblasts Others | 98 / 6329 (1.5%) | 3935 / 63290 (6.2%) | −68.6 | −66.5 | 0.25 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 106 / 6329 (1.7%) | 4080 / 63290 (6.4%) | −68.5 | −66.5 | 0.26 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 101 / 6329 (1.6%) | 3990 / 63290 (6.3%) | −68.5 | −66.5 | 0.25 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 220 / 6329 (3.5%) | 5935 / 63290 (9.4%) | −68.5 | −66.5 | 0.37 |
| BRD4 SRX23813262 | C4-2B Prostate | 628 / 6329 (9.9%) | 2758 / 63290 (4.4%) | −68.4 | −66.4 | 2.28 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 162 / 6329 (2.6%) | 5023 / 63290 (7.9%) | −68.4 | −66.4 | 0.32 |
| CEBPB SRX150632 | HeLa Uterus | 283 / 6329 (4.5%) | 6875 / 63290 (10.9%) | −68.4 | −66.4 | 0.41 |
| KDM2B SRX3256875 | hESC H1 Pluripotent stem cell | 1126 / 6329 (17.8%) | 6387 / 63290 (10.1%) | −68.3 | −66.3 | 1.76 |
| MYH11 SRX265220 | ME-1 Blood | 352 / 6329 (5.6%) | 1074 / 63290 (1.7%) | −68.3 | −66.3 | 3.28 |
| BCOR SRX10184504 | OCI-AML3 Blood | 634 / 6329 (10.0%) | 2800 / 63290 (4.4%) | −68.2 | −66.2 | 2.26 |
| NCAPH2 SRX2731518 | 293 Kidney | 525 / 6329 (8.3%) | 2094 / 63290 (3.3%) | −68.2 | −66.2 | 2.51 |
| FOXA1 SRX371480 | MCF-7 Breast | 78 / 6329 (1.2%) | 3557 / 63290 (5.6%) | −68.2 | −66.2 | 0.22 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 109 / 6329 (1.7%) | 4119 / 63290 (6.5%) | −68.1 | −66.1 | 0.26 |
| SUZ12 SRX4650972 | 293 Kidney | 135 / 6329 (2.1%) | 130 / 63290 (0.2%) | −67.9 | −66.0 | 10.38 |
| SUZ12 SRX4650918 | 293 Kidney | 162 / 6329 (2.6%) | 214 / 63290 (0.3%) | −67.9 | −65.9 | 7.57 |
| ERG SRX063917 | MCF-7 Breast | 579 / 6329 (9.1%) | 2446 / 63290 (3.9%) | −67.9 | −65.9 | 2.37 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 122 / 6329 (1.9%) | 4337 / 63290 (6.9%) | −67.8 | −65.8 | 0.28 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 416 / 6329 (6.6%) | 8714 / 63290 (13.8%) | −67.8 | −65.8 | 0.48 |
| RNF2 SRX19321949 | MCF-7 Breast | 170 / 6329 (2.7%) | 242 / 63290 (0.4%) | −67.8 | −65.8 | 7.02 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 153 / 6329 (2.4%) | 4854 / 63290 (7.7%) | −67.7 | −65.7 | 0.32 |
| FOXA1 SRX3923514 | MCF-7 Breast | 123 / 6329 (1.9%) | 4349 / 63290 (6.9%) | −67.6 | −65.6 | 0.28 |
| CSTF2 SRX10448647 | HeLa Uterus | 392 / 6329 (6.2%) | 1305 / 63290 (2.1%) | −67.6 | −65.6 | 3.00 |
| FOXA2 SRX3644355 | BJ Epidermis | 58 / 6329 (0.9%) | 3144 / 63290 (5.0%) | −67.5 | −65.6 | 0.18 |
| LARP7 SRX1177904 | HCT 116 Digestive tract | 457 / 6329 (7.2%) | 1686 / 63290 (2.7%) | −67.5 | −65.5 | 2.71 |
| FOXA1 SRX219284 | LNCAP Prostate | 167 / 6329 (2.6%) | 5070 / 63290 (8.0%) | −67.4 | −65.4 | 0.33 |
| GFP SRX1514953 | 293 Kidney | 957 / 6329 (15.1%) | 5125 / 63290 (8.1%) | −67.4 | −65.4 | 1.87 |
| FOXA1 SRX3931055 | MCF-7 Breast | 98 / 6329 (1.5%) | 3900 / 63290 (6.2%) | −67.3 | −65.4 | 0.25 |
| RNF2 SRX19321948 | MCF-7 Breast | 152 / 6329 (2.4%) | 184 / 63290 (0.3%) | −67.3 | −65.3 | 8.26 |
| BCOR SRX10184505 | KG-1 Blood | 381 / 6329 (6.0%) | 1248 / 63290 (2.0%) | −67.2 | −65.2 | 3.05 |
| ERG SRX026657 | Acute promyelocytic leukemia Blood | 738 / 6329 (11.7%) | 3537 / 63290 (5.6%) | −67.1 | −65.2 | 2.09 |
| STAT5A SRX9681372 | ARP-1 Blood | 557 / 6329 (8.8%) | 2319 / 63290 (3.7%) | −67.1 | −65.1 | 2.40 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 252 / 6329 (4.0%) | 6367 / 63290 (10.1%) | −67.0 | −65.0 | 0.40 |
| RNF2 SRX19321943 | MCF-7 Breast | 165 / 6329 (2.6%) | 229 / 63290 (0.4%) | −66.9 | −65.0 | 7.21 |
| GFP SRX17864030 | 293 Kidney | 593 / 6329 (9.4%) | 2556 / 63290 (4.0%) | −66.9 | −64.9 | 2.32 |
| FOXA1 SRX1787655 | MCF-7 Breast | 51 / 6329 (0.8%) | 2982 / 63290 (4.7%) | −66.9 | −64.9 | 0.17 |
| WWTR1 SRX10119378 | MCF 10A Breast | 133 / 6329 (2.1%) | 4491 / 63290 (7.1%) | −66.9 | −64.9 | 0.30 |
| KDM2B SRX3256876 | hESC H1 Pluripotent stem cell | 1104 / 6329 (17.4%) | 6262 / 63290 (9.9%) | −66.8 | −64.9 | 1.76 |
| STAT3 SRX150630 | MCF 10A Breast | 108 / 6329 (1.7%) | 4059 / 63290 (6.4%) | −66.8 | −64.8 | 0.27 |
| ZNF711 SRX7805362 | 293 Kidney | 582 / 6329 (9.2%) | 2487 / 63290 (3.9%) | −66.8 | −64.8 | 2.34 |
| STAT3 SRX150479 | MCF 10A Breast | 109 / 6329 (1.7%) | 4077 / 63290 (6.4%) | −66.8 | −64.8 | 0.27 |
| FOXA1 SRX11222437 | MCF-7 Breast | 79 / 6329 (1.2%) | 3532 / 63290 (5.6%) | −66.7 | −64.8 | 0.22 |
| STAT3 SRX150536 | MCF 10A Breast | 139 / 6329 (2.2%) | 4590 / 63290 (7.3%) | −66.7 | −64.8 | 0.30 |
| EP300 SRX24299743 | hESC H9 Pluripotent stem cell | 653 / 6329 (10.3%) | 2960 / 63290 (4.7%) | −66.7 | −64.7 | 2.21 |
| ESR1 SRX371469 | MCF-7 Breast | 137 / 6329 (2.2%) | 4550 / 63290 (7.2%) | −66.6 | −64.7 | 0.30 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 221 / 6329 (3.5%) | 5886 / 63290 (9.3%) | −66.6 | −64.7 | 0.38 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 115 / 6329 (1.8%) | 4167 / 63290 (6.6%) | −66.3 | −64.4 | 0.28 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 133 / 6329 (2.1%) | 4476 / 63290 (7.1%) | −66.3 | −64.3 | 0.30 |
| SUZ12 SRX4650933 | 293 Kidney | 149 / 6329 (2.4%) | 179 / 63290 (0.3%) | −66.3 | −64.3 | 8.32 |
| RNF2 SRX9555211 | 293 Kidney | 147 / 6329 (2.3%) | 173 / 63290 (0.3%) | −66.2 | −64.2 | 8.50 |
| TRIM24 SRX1041842 | LNCAP Prostate | 459 / 6329 (7.3%) | 1720 / 63290 (2.7%) | −66.1 | −64.2 | 2.67 |
| HIF1A SRX20663235 | HK-2 Kidney | 140 / 6329 (2.2%) | 152 / 63290 (0.2%) | −66.1 | −64.1 | 9.21 |
| KDM2B SRX1873447 | SEM Blood | 939 / 6329 (14.8%) | 5027 / 63290 (7.9%) | −66.0 | −64.1 | 1.87 |
| NKX2-1 SRX2164786 | A549 Lung | 216 / 6329 (3.4%) | 5784 / 63290 (9.1%) | −65.9 | −63.9 | 0.37 |
| AR SRX1067069 | LHSAR Prostate | 152 / 6329 (2.4%) | 4778 / 63290 (7.5%) | −65.9 | −63.9 | 0.32 |
| RNF2 SRX9281780 | 293 Kidney | 125 / 6329 (2.0%) | 110 / 63290 (0.2%) | −65.8 | −63.9 | 11.36 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 148 / 6329 (2.3%) | 4708 / 63290 (7.4%) | −65.8 | −63.9 | 0.31 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 148 / 6329 (2.3%) | 4708 / 63290 (7.4%) | −65.8 | −63.9 | 0.31 |
| RAC1 SRX10365543 | MCF-7 Breast | 58 / 6329 (0.9%) | 3088 / 63290 (4.9%) | −65.6 | −63.7 | 0.19 |
| JADE3 DRX300415 | 293 Kidney | 594 / 6329 (9.4%) | 2588 / 63290 (4.1%) | −65.6 | −63.7 | 2.30 |
| Epitope tags SRX16749709 | SYO-1 Others | 437 / 6329 (6.9%) | 1595 / 63290 (2.5%) | −65.6 | −63.6 | 2.74 |
| Epitope tags SRX4192709 | MDA-MB-231 Breast | 235 / 6329 (3.7%) | 519 / 63290 (0.8%) | −65.5 | −63.6 | 4.53 |
| Epitope tags SRX667414 | MCF-7 Breast | 619 / 6329 (9.8%) | 2760 / 63290 (4.4%) | −65.4 | −63.4 | 2.24 |
| ESR1 SRX194572 | MCF-7 Breast | 78 / 6329 (1.2%) | 3463 / 63290 (5.5%) | −65.1 | −63.2 | 0.23 |
| JUN SRX883584 | MDA-MB-231 Breast | 205 / 6329 (3.2%) | 5582 / 63290 (8.8%) | −65.0 | −63.0 | 0.37 |
| RNF2 SRX4650927 | 293 Kidney | 136 / 6329 (2.1%) | 145 / 63290 (0.2%) | −64.8 | −62.9 | 9.38 |
| MEN1 SRX11712604 | K-562 Blood | 548 / 6329 (8.7%) | 2306 / 63290 (3.6%) | −64.6 | −62.7 | 2.38 |
| GATA3 SRX11150130 | Breast cancer cells Breast | 200 / 6329 (3.2%) | 5489 / 63290 (8.7%) | −64.5 | −62.6 | 0.36 |
| FOS SRX3322636 | MCF-7 Breast | 77 / 6329 (1.2%) | 3426 / 63290 (5.4%) | −64.5 | −62.5 | 0.22 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 384 / 6329 (6.1%) | 8136 / 63290 (12.9%) | −64.4 | −62.5 | 0.47 |
| CREBBP SRX359409 | 293 Kidney | 625 / 6329 (9.9%) | 2821 / 63290 (4.5%) | −64.3 | −62.4 | 2.22 |
| ZBTB26 SRX3322068 | 293 Kidney | 708 / 6329 (11.2%) | 3394 / 63290 (5.4%) | −64.3 | −62.4 | 2.09 |
| ESR1 SRX371470 | ZR-75-1 Breast | 118 / 6329 (1.9%) | 4144 / 63290 (6.5%) | −64.0 | −62.1 | 0.28 |
| AR SRX9469988 | LAPC-4 Prostate | 177 / 6329 (2.8%) | 5109 / 63290 (8.1%) | −63.9 | −62.0 | 0.35 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 194 / 6329 (3.1%) | 5374 / 63290 (8.5%) | −63.8 | −61.9 | 0.36 |
| GFP SRX5486428 | HCT 116 Digestive tract | 590 / 6329 (9.3%) | 2599 / 63290 (4.1%) | −63.7 | −61.8 | 2.27 |
| BCOR SRX3256874 | hESC H1 Pluripotent stem cell | 781 / 6329 (12.3%) | 3926 / 63290 (6.2%) | −63.7 | −61.8 | 1.99 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 103 / 6329 (1.6%) | 3872 / 63290 (6.1%) | −63.7 | −61.7 | 0.27 |
| CEBPB SRX1027446 | Mesenchymal stem cells Others | 90 / 6329 (1.4%) | 3634 / 63290 (5.7%) | −63.5 | −61.6 | 0.25 |
| SUZ12 SRX9555216 | 293 Kidney | 133 / 6329 (2.1%) | 142 / 63290 (0.2%) | −63.4 | −61.5 | 9.37 |
| FOS SRX070879 | HUVEC Cardiovascular | 133 / 6329 (2.1%) | 4373 / 63290 (6.9%) | −63.1 | −61.2 | 0.30 |
| SUZ12 SRX9281790 | 293 Kidney | 131 / 6329 (2.1%) | 137 / 63290 (0.2%) | −63.1 | −61.2 | 9.56 |
| SMARCA4 SRX5212362 | Mel270 Others | 234 / 6329 (3.7%) | 5955 / 63290 (9.4%) | −63.1 | −61.2 | 0.39 |
| ESR1 SRX7624157 | MCF-7 Breast | 352 / 6329 (5.6%) | 7640 / 63290 (12.1%) | −63.1 | −61.1 | 0.46 |
| SS18 SRX3468047 | Fibroblasts Others | 342 / 6329 (5.4%) | 7503 / 63290 (11.9%) | −63.0 | −61.1 | 0.46 |
| FOXA1 SRX1787652 | MCF-7 Breast | 73 / 6329 (1.2%) | 3305 / 63290 (5.2%) | −63.0 | −61.1 | 0.22 |
| FOXA1 SRX028635 | MCF-7 Breast | 53 / 6329 (0.8%) | 2900 / 63290 (4.6%) | −62.6 | −60.7 | 0.18 |
| GATA3 SRX5457550 | MCF-7 Breast | 150 / 6329 (2.4%) | 4632 / 63290 (7.3%) | −62.6 | −60.7 | 0.32 |
| FOXA1 SRX1787651 | MCF-7 Breast | 67 / 6329 (1.1%) | 3174 / 63290 (5.0%) | −62.5 | −60.5 | 0.21 |
| RNF2 SRX4650966 | 293 Kidney | 122 / 6329 (1.9%) | 114 / 63290 (0.2%) | −62.4 | −60.5 | 10.70 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 586 / 6329 (9.3%) | 2598 / 63290 (4.1%) | −62.4 | −60.5 | 2.26 |
| ESR1 SRX7624156 | MCF-7 Breast | 219 / 6329 (3.5%) | 5700 / 63290 (9.0%) | −62.4 | −60.4 | 0.38 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 117 / 6329 (1.8%) | 4073 / 63290 (6.4%) | −62.3 | −60.4 | 0.29 |
| RNF2 SRX9555215 | 293 Kidney | 147 / 6329 (2.3%) | 191 / 63290 (0.3%) | −62.3 | −60.4 | 7.70 |
| KAT7 DRX300414 | 293 Kidney | 247 / 6329 (3.9%) | 603 / 63290 (1.0%) | −62.2 | −60.3 | 4.10 |
| TP53 SRX396254 | Fibroblasts Others | 339 / 6329 (5.4%) | 1079 / 63290 (1.7%) | −62.1 | −60.2 | 3.14 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 74 / 6329 (1.2%) | 3300 / 63290 (5.2%) | −62.1 | −60.2 | 0.22 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 119 / 6329 (1.9%) | 4096 / 63290 (6.5%) | −62.0 | −60.1 | 0.29 |
| FOXL2 SRX6957477 | KGN Gonad | 133 / 6329 (2.1%) | 4327 / 63290 (6.8%) | −61.9 | −60.0 | 0.31 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 173 / 6329 (2.7%) | 4971 / 63290 (7.9%) | −61.7 | −59.8 | 0.35 |
| ESR1 SRX371479 | MCF-7 Breast | 129 / 6329 (2.0%) | 4255 / 63290 (6.7%) | −61.7 | −59.8 | 0.30 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 124 / 6329 (2.0%) | 4173 / 63290 (6.6%) | −61.7 | −59.8 | 0.30 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 304 / 6329 (4.8%) | 6911 / 63290 (10.9%) | −61.6 | −59.7 | 0.44 |
| FOXA1 SRX11222441 | MCF-7 Breast | 93 / 6329 (1.5%) | 3628 / 63290 (5.7%) | −61.5 | −59.6 | 0.26 |
| SETD1A SRX23734379 | MOLM-13 Blood | 470 / 6329 (7.4%) | 1866 / 63290 (2.9%) | −61.4 | −59.5 | 2.52 |
| FOXA1 SRX3923517 | MCF-7 Breast | 87 / 6329 (1.4%) | 3514 / 63290 (5.6%) | −61.3 | −59.4 | 0.25 |
| ESR1 SRX371468 | MCF-7 Breast | 86 / 6329 (1.4%) | 3493 / 63290 (5.5%) | −61.2 | −59.3 | 0.25 |
| SUZ12 SRX4650915 | 293 Kidney | 148 / 6329 (2.3%) | 200 / 63290 (0.3%) | −61.2 | −59.3 | 7.40 |
| RNF2 SRX19321944 | MCF-7 Breast | 154 / 6329 (2.4%) | 221 / 63290 (0.3%) | −61.1 | −59.2 | 6.97 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 304 / 6329 (4.8%) | 902 / 63290 (1.4%) | −61.1 | −59.2 | 3.37 |
| GATA3 SRX11149845 | MDA-MB-453 Breast | 139 / 6329 (2.2%) | 4402 / 63290 (7.0%) | −61.0 | −59.2 | 0.32 |
| SUZ12 SRX4650914 | 293 Kidney | 151 / 6329 (2.4%) | 211 / 63290 (0.3%) | −61.0 | −59.1 | 7.16 |
| CDYL2 SRX8321655 | MCF-7 Breast | 302 / 6329 (4.8%) | 893 / 63290 (1.4%) | −61.0 | −59.1 | 3.38 |
| Crotonyllysine SRX12306536 | Polycystic kidney Kidney | 602 / 6329 (9.5%) | 2738 / 63290 (4.3%) | −60.8 | −59.0 | 2.20 |
| FOXA1 SRX9604647 | LNCAP Prostate | 204 / 6329 (3.2%) | 5420 / 63290 (8.6%) | −60.8 | −58.9 | 0.38 |
| KDM4A SRX5266973 | THP-1 Blood | 713 / 6329 (11.3%) | 3513 / 63290 (5.6%) | −60.8 | −58.9 | 2.03 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 106 / 6329 (1.7%) | 3833 / 63290 (6.1%) | −60.7 | −58.9 | 0.28 |
| SUZ12 SRX4650954 | 293 Kidney | 127 / 6329 (2.0%) | 135 / 63290 (0.2%) | −60.7 | −58.8 | 9.41 |
| CRTC2 SRX5576990 | A549 Lung | 713 / 6329 (11.3%) | 3518 / 63290 (5.6%) | −60.5 | −58.6 | 2.03 |
| Epitope tags SRX667411 | MCF-7 Breast | 530 / 6329 (8.4%) | 2267 / 63290 (3.6%) | −60.5 | −58.6 | 2.34 |
| JUND SRX150408 | HeLa Uterus | 114 / 6329 (1.8%) | 3961 / 63290 (6.3%) | −60.4 | −58.5 | 0.29 |
| ZFX SRX7805365 | 22Rv1 Prostate | 529 / 6329 (8.4%) | 2260 / 63290 (3.6%) | −60.4 | −58.5 | 2.34 |
| WWTR1 SRX10119367 | MCF 10A Breast | 159 / 6329 (2.5%) | 4705 / 63290 (7.4%) | −60.4 | −58.5 | 0.34 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 121 / 6329 (1.9%) | 4076 / 63290 (6.4%) | −60.3 | −58.5 | 0.30 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 193 / 6329 (3.0%) | 5230 / 63290 (8.3%) | −60.3 | −58.5 | 0.37 |
| AGO1 SRX3322427 | K-562 Blood | 188 / 6329 (3.0%) | 356 / 63290 (0.6%) | −60.3 | −58.4 | 5.28 |
| TEAD1 SRX3401272 | MCF-7 Breast | 97 / 6329 (1.5%) | 3660 / 63290 (5.8%) | −60.3 | −58.4 | 0.27 |
| JUND SRX699738 | HCASMC Cardiovascular | 187 / 6329 (3.0%) | 5140 / 63290 (8.1%) | −60.3 | −58.4 | 0.36 |
| SMARCA2 SRX8119677 | MeT-5A Others | 227 / 6329 (3.6%) | 5746 / 63290 (9.1%) | −60.3 | −58.4 | 0.40 |
| BRD4 SRX2166886 | Retina Neural | 677 / 6329 (10.7%) | 3271 / 63290 (5.2%) | −60.2 | −58.3 | 2.07 |
| EP300 SRX24299742 | hESC H9 Pluripotent stem cell | 656 / 6329 (10.4%) | 3127 / 63290 (4.9%) | −60.1 | −58.2 | 2.10 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 138 / 6329 (2.2%) | 4353 / 63290 (6.9%) | −60.1 | −58.2 | 0.32 |
| FOXA1 SRX11222442 | MCF-7 Breast | 81 / 6329 (1.3%) | 3367 / 63290 (5.3%) | −60.1 | −58.2 | 0.24 |
| CTCF SRX13551281 | Adipose stem cells Adipocyte | 1122 / 6329 (17.7%) | 6623 / 63290 (10.5%) | −60.0 | −58.1 | 1.69 |
| BRD2 SRX8090652 | Synoviocytes Others | 455 / 6329 (7.2%) | 1797 / 63290 (2.8%) | −59.9 | −58.1 | 2.53 |
| ESR1 SRX371471 | ZR-75-1 Breast | 151 / 6329 (2.4%) | 4558 / 63290 (7.2%) | −59.9 | −58.1 | 0.33 |
| SUZ12 SRX4650935 | 293 Kidney | 139 / 6329 (2.2%) | 176 / 63290 (0.3%) | −59.9 | −58.0 | 7.90 |
| ESR1 SRX10365536 | MCF-7 Breast | 68 / 6329 (1.1%) | 3118 / 63290 (4.9%) | −59.9 | −58.0 | 0.22 |
| FOSL2 SRX190296 | SK-N-SH Neural | 185 / 6329 (2.9%) | 5095 / 63290 (8.1%) | −59.9 | −58.0 | 0.36 |
| WAS SRX5371248 | Lymphoblastoid cell line Blood | 366 / 6329 (5.8%) | 1263 / 63290 (2.0%) | −59.8 | −57.9 | 2.90 |
| SUZ12 SRX9281793 | 293 Kidney | 110 / 6329 (1.7%) | 91 / 63290 (0.1%) | −59.7 | −57.9 | 12.09 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 493 / 6329 (7.8%) | 2042 / 63290 (3.2%) | −59.7 | −57.8 | 2.41 |
| MCM2 SRX12221306 | HCT 116 Digestive tract | 507 / 6329 (8.0%) | 2131 / 63290 (3.4%) | −59.7 | −57.8 | 2.38 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 101 / 6329 (1.6%) | 3710 / 63290 (5.9%) | −59.6 | −57.8 | 0.27 |
| GATA3 SRX11150129 | Breast cancer cells Breast | 186 / 6329 (2.9%) | 5100 / 63290 (8.1%) | −59.6 | −57.7 | 0.36 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 271 / 6329 (4.3%) | 6361 / 63290 (10.1%) | −59.6 | −57.7 | 0.43 |
| RNF2 SRX4650928 | 293 Kidney | 128 / 6329 (2.0%) | 143 / 63290 (0.2%) | −59.5 | −57.6 | 8.95 |
| SMARCA4 SRX5212357 | Mel270 Others | 202 / 6329 (3.2%) | 5342 / 63290 (8.4%) | −59.5 | −57.6 | 0.38 |
| FOXA1 SRX3923518 | MCF-7 Breast | 86 / 6329 (1.4%) | 3437 / 63290 (5.4%) | −59.4 | −57.6 | 0.25 |
| FOXA1 SRX2017929 | LNCAP Prostate | 175 / 6329 (2.8%) | 4920 / 63290 (7.8%) | −59.4 | −57.6 | 0.36 |
| FOXA1 SRX028634 | MCF-7 Breast | 59 / 6329 (0.9%) | 2930 / 63290 (4.6%) | −59.4 | −57.6 | 0.20 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 85 / 6329 (1.3%) | 3418 / 63290 (5.4%) | −59.3 | −57.5 | 0.25 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 183 / 6329 (2.9%) | 5040 / 63290 (8.0%) | −59.3 | −57.5 | 0.36 |
| VGLL1 SRX18013277 | FULVR Breast | 50 / 6329 (0.8%) | 2736 / 63290 (4.3%) | −58.9 | −57.1 | 0.18 |
| FOXA1 SRX3923516 | MCF-7 Breast | 93 / 6329 (1.5%) | 3542 / 63290 (5.6%) | −58.7 | −56.9 | 0.26 |
| TLE3 SRX4815192 | MCF-7 Breast | 123 / 6329 (1.9%) | 4058 / 63290 (6.4%) | −58.7 | −56.9 | 0.30 |
| SUZ12 SRX4650913 | 293 Kidney | 149 / 6329 (2.4%) | 217 / 63290 (0.3%) | −58.5 | −56.7 | 6.87 |
| FOXA1 SRX1161174 | MCF-7 Breast | 139 / 6329 (2.2%) | 4316 / 63290 (6.8%) | −58.5 | −56.7 | 0.32 |
| RNF2 SRX4650907 | 293 Kidney | 139 / 6329 (2.2%) | 183 / 63290 (0.3%) | −58.4 | −56.6 | 7.60 |
| FOXA1 SRX3931033 | MCF-7 Breast | 81 / 6329 (1.3%) | 3318 / 63290 (5.2%) | −58.4 | −56.6 | 0.24 |
| TET2 SRX2513052 | Jurkat Blood | 552 / 6329 (8.7%) | 2452 / 63290 (3.9%) | −58.4 | −56.5 | 2.25 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 289 / 6329 (4.6%) | 854 / 63290 (1.3%) | −58.4 | −56.5 | 3.38 |
| Epitope tags SRX1055111 | 293 Kidney | 1167 / 6329 (18.4%) | 7034 / 63290 (11.1%) | −58.4 | −56.5 | 1.66 |
| KDM5A SRX23740438 | SUM 149PT Breast | 644 / 6329 (10.2%) | 3084 / 63290 (4.9%) | −58.3 | −56.5 | 2.09 |
| ELF1 SRX265229 | ME-1 Blood | 379 / 6329 (6.0%) | 1361 / 63290 (2.2%) | −58.3 | −56.4 | 2.78 |
| CSTF2 SRX10448646 | HeLa Uterus | 309 / 6329 (4.9%) | 963 / 63290 (1.5%) | −58.2 | −56.4 | 3.21 |
| FOXA1 SRX1885181 | LNCAP Prostate | 120 / 6329 (1.9%) | 3990 / 63290 (6.3%) | −58.2 | −56.4 | 0.30 |
| SMARCA4 SRX5212366 | Mel270 Others | 188 / 6329 (3.0%) | 5078 / 63290 (8.0%) | −58.2 | −56.3 | 0.37 |
| ESR1 SRX371477 | MCF-7 Breast | 64 / 6329 (1.0%) | 2988 / 63290 (4.7%) | −58.1 | −56.3 | 0.21 |
| ZNF768 SRX10478010 | Hep G2 Liver | 1122 / 6329 (17.7%) | 6686 / 63290 (10.6%) | −58.0 | −56.2 | 1.68 |
| SUZ12 SRX9555217 | 293 Kidney | 121 / 6329 (1.9%) | 128 / 63290 (0.2%) | −58.0 | −56.2 | 9.45 |
| IRF3 SRX11453864 | Hep G2 Liver | 76 / 6329 (1.2%) | 23 / 63290 (0.0%) | −58.0 | −56.1 | 33.04 |
| SMARCA4 SRX5212371 | Mel270 Others | 199 / 6329 (3.1%) | 5237 / 63290 (8.3%) | −57.9 | −56.0 | 0.38 |
| FOXA1 SRX5323843 | MCF-7 Breast | 67 / 6329 (1.1%) | 3036 / 63290 (4.8%) | −57.9 | −56.0 | 0.22 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 62 / 6329 (1.0%) | 2939 / 63290 (4.6%) | −57.7 | −55.9 | 0.21 |
| FOXA1 SRX219285 | LNCAP Prostate | 125 / 6329 (2.0%) | 4056 / 63290 (6.4%) | −57.7 | −55.9 | 0.31 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 196 / 6329 (3.1%) | 409 / 63290 (0.6%) | −57.7 | −55.9 | 4.79 |
| HDAC1 SRX17989500 | PBMC Blood | 596 / 6329 (9.4%) | 2767 / 63290 (4.4%) | −57.6 | −55.8 | 2.15 |
| STAT1 SRX23678708 | K-562 Blood | 566 / 6329 (8.9%) | 2564 / 63290 (4.1%) | −57.6 | −55.8 | 2.21 |
Showing first 500 of 11699 rows.